Europa Trial
Home
Sitemap
General Public Heathcare Professionals Virtual Press Office
 

New Indication in CAD

Media Alert 2005


EUROPA calendar
ACC 2006 - Posters
ESC 2005 - Symposium
ESC 2005 - Oral sessions
ESC 2005 - Posters
AHA 2004 - Oral Session
ESC 2004 - Hotline
ESC 2004 - Symposium
ACC 2004
ESC 2003


EUROPA Study
Press Kit Material 2004
Press Conference - Webcast
EUROPA findings
EUROPA investigators
EUROPA main results
EUROPA publications


EUROPA Slide Set
Rationale and Design
Results
Clinical Implications


PERSUADE

PERSUADE Publications
PERSUADE Press Release
PERSUADE Results
PERSUADE Data Sheet
Diabetes and Cardiovascular Diseases
PERSUADE Quotable Quotes
PERSUADE collaborating centres


PERTINENT

Media Alert 2004
PERTINENT Press Release
PERTINENT Results
PERTINENT Fact Sheet
Background on CAD
PERTINENT Quotable Quotes
Perindopril Fact Sheet
Glossary


Contact
Home : Virtual Press Office : Identification page
Identification page
If you are already registered as a journalist, to log in or modify your account, plase enter your Username and Password below :
"I confirm that I am a journalist, and therefore meet the conditions required to access to the Virtual Press Office".
Login  
Password
   
  I forgot my password
I want to modify my profile
 
This website is intended for an international audience. Drug related information may refer to unlicensed products or uses which may not be approved in your own country and you should therefore consult your local prescribing information.
This site is published and updated by the EUROPA study investigators. Site last updated March 21st 2006
To report a suspected side-effect with a Servier drug, please click here.
Terms of use - ©2005 EUROPA All rights reserved